Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns

Why did defense stocks rise after Iran strikes? How did Tesla’s robotaxi launch impact stock price? Why did Novo Nordisk shares fall recently? What effect could Iran closing the Strait of Hormuz have? How are oil prices reacting to US-Iran tensions? Why is Apple negotiating App Store changes with EU? How is Iran conflict affecting global stock markets?

Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns

benzinga.com/news/health-care/25/06/46048974/eli-lillys-investigational-oral-pill-shows-weight-loss-benefits-with-lingering-side-effect-conce

Eli Lilly And Co (NYSE:LLY) on Saturday announced detailed results from the ACHIEVE-1 Phase 3 trial of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
The company released its topline data from the trial in…

This story appeared on benzinga.com, 2025-06-23 11:45:30.